Gyre Therapeutics names Ying Luo CEO.
Gyre Therapeutics, Inc. dated October 16, 2026, agreed to employ Ying Luo as Chief Executive Officer at an annual base salary of $500,000.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed